StockData
SeaStar Medical Holding Corp logo

SeaStar Medical Holding Corp (ICUCW) stock

ICUCWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 3/309% above fair value
$0.01−0.01 (-34.73%)

Close on Oct 30, 2026Market cap $9.87MP/E –Yield –

SeaStar Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

SeaStar Medical's operating income for the twelve months ending Jun 30, 2026 was -$13.99M. For fiscal 2025 it was -$12.18M. The highest annual figure on record is -$4.45M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.18M–
FY2024Dec 31, 2024-$17.84M–
FY2023Dec 31, 2023-$14.21M–
FY2022Dec 31, 2022-$11.61M–
FY2021Dec 31, 2021-$4.45M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.79M–
Q1 FY2026Mar 31, 2026-$3.60M–
Q4 FY2025Dec 31, 2025-$3.02M–
Q3 FY2025Sep 30, 2025-$3.58M–
Q2 FY2025Jun 30, 2025-$1.76M–
Q1 FY2025Mar 31, 2025-$3.82M–
Q4 FY2024Dec 31, 2024-$4.77M–
Q3 FY2024Sep 30, 2024-$4.46M–
Q2 FY2024Jun 30, 2024-$4.67M–
Q1 FY2024Mar 31, 2024-$3.95M–
Q4 FY2023Dec 31, 2023-$2.94M–
Q3 FY2023Sep 30, 2023-$2.94M–
Q2 FY2023Jun 30, 2023-$3.75M–
Q1 FY2023Mar 31, 2023-$4.58M–
Q4 FY2022Dec 31, 2022-$7.72M–
Q3 FY2022Sep 30, 2022-$1.77M–
Q2 FY2022Jun 30, 2022-$1.31M–
Q1 FY2022Mar 31, 2022-$812.00K–
Q4 FY2021Dec 31, 2021-$3.70M–
Q3 FY2021Sep 30, 2021-$411.40K–
Q2 FY2021Jun 30, 2021-$209.72K–
Q1 FY2021Mar 31, 2021-$125.96K–

More SeaStar Medical figures